You're contacting media contact of this press release

Title: CoreAge Rx Expands Telehealth Portfolio with Launch of Sermorelin and NAD+ Therapies

Wichita Falls, TX, United States, 21st Apr 2026 - CoreAge Rx, a LegitScript-certified telehealth provider, has announced the launch of three new treatment options on its platform: Sermorelin therapy, NAD+ Nasal Spray, and NAD+ Injectable. The expansion reflects the company’s continued focus on providing accessible, physician-guided therapies designed to support energy, recovery, and overall wellness through a fully online care model.The newly introduced treatments are now available through CoreAge Rx’s digital platform, where patients can complete a health assessment, receive physician review, and have prescriptions delivered directly to their door if approved.Introduction of Sermorelin Therapy for Hormone SupportAmong the newly launched offerings is Sermorelin, a growth hormone-releasing hormone (GHRH) therapy designed to stimulate the body’s natural production of human growth hormone (HGH). By acting on the hypothalamus and signaling the pituitary gland, Sermorelin supports increased HGH levels and subsequent production of insulin-like growth factor 1 (IGF-1).This mechanism plays a role in several physiological functions, including metabolism, muscle development, and bone strength. As a therapy that encourages endogenous hormone production, Sermorelin is positioned as an alternative approach compared to synthetic hormone administration.CoreAge Rx highlights that patients using Sermorelin therapy may experience benefits such as improved sleep quality, enhanced muscle mass, support for fat metabolism, improved skin and hair appearance, and increased energy levels. The therapy is offered starting at $195 for a one-month supply.NAD+ Nasal Spray Designed for Cognitive and Energy SupportCoreAge Rx has also introduced NAD+ Nasal Spray, a fast-acting formulation designed to s...

This press release is issued by King Newswire